1. Experimental approach in the use of magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent;Meyers;Am. J. Roentgenol. Radium Therapy, Nucl. Med.,1963
2. Preclinical experiences with magnetic drug targeting: tolerance and efficacy;Lübbe,1996
3. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors;Lübbe;Cancer Res.,1996
4. Ferromagnetic silicon necrosis hypermephosmas by selective vascular occlusion to the tumor: a new technique;Turner;J. Urol.,1975
5. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy;Goodwin;J. Magn. Magn. Matr.,1999